Previous Article | Next Article 
Journal of Bacteriology, April 2000, p. 1812-1818, Vol. 182, No. 7
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Reinvestigation of the Proteolytic Activity
of Neocarzinostatin
Bernadette
Heyd,1
Guilhem
Lerat,1
Elisabeth
Adjadj,2
Philippe
Minard,1 and
Michel
Desmadril1,*
Laboratoire de Modélisation et
d'Ingénierie des Protéines,
EP1088,1 and Laboratoire de Biophysique
Moléculaire, INSERM U 350, Institut
Curie,2 Université de Paris-Sud, F-91405
Orsay Cedex, France
Received 11 October 1999/Accepted 17 December 1999
 |
ABSTRACT |
Neocarzinostatin (NCS) is the most studied member of a family of
chromoproteins secreted by a range of actinomycetes species. It has
been proposed that in addition to their antitumoral activity related to
the bound chromophores, this group of related proteins could be a
secreted proteases superfamily. With the aim of dissecting the
molecular basis of the proteolytic activity of NCS, an expression system allowing efficient expression of apo-NCS in Escherichia coli was constructed. The recombinant protein was properly folded and functional. Its histone-specific proteolytic activity was similar
to the activity described for the natural protein. Further analyses
unambiguously demonstrated that the proteolytic activity could be
physically separated from NCS. This activity is therefore due not to
NCS itself but to minor contaminating proteases, the nature of which
differed in the recombinant and natural NCS preparations. The histone
degradation test commonly used to monitor proteolytic activity is
extremely sensitive and may easily generate false-positive results.
These results strongly suggest that the possible proteolytic activity
of the proteins of this family should be critically reconsidered.
 |
INTRODUCTION |
Neocarzinostatin (NCS), isolated
from Streptomyces carzinostaticus, is a complex consisting
of a low-molecular-weight enediyne chromophore, tightly bound
(Kd = 0.1 nM [8]) to a
113-amino-acid single chain protein (2, 13, 19). NCS belongs
to a family of macromolecular chromoprotein antibiotics that also have
antitumoral activity. The known members of this family are NCS,
macromomycin (secreted by Streptomyces macromomyceticus),
C-1027 and actinoxantin (secreted by Streptomyces
globisporus), maduropeptin (secreted by Actinomadura
madurae), and kedarcidin (secreted by an unidentified species of
actinomycetes). With the exception of maduropeptin, the amino acid
sequence of which has not yet been determined and the molecular weight
of which is significantly higher than those of the other proteins, all
proteins of this family have clearly related amino acid sequences. The
antibiotic and antitumor activity of these compounds is due to the
low-molecular-weight enediyne moiety. These enediyne-containing
molecules form highly reactive biradical intermediates that cleave DNA
at sequence-specific sites (3, 9, 10, 20). It has been
suggested that the function of the apoprotein is essentially to
stabilize and regulate the availability of the otherwise labile
chromophore (11). However, studies with some proteins have
detected proteolytic activity associated to the polypeptide moiety of
the complex. Each chromoprotein seems to have a characteristic
proteolytic specificity (22). Whereas C-1027 (18)
and macromomycin (21) seem to have aminopeptidase activity,
endopeptidase activity has been shown for kedarcidin (18),
maduropeptin, and NCS (23, 24).
These activities have been detected with either histones (18,
21-24) or synthetic peptides (24). Histones were
chosen as substrates because it was thought that these highly basic
proteins would probably interact with the acid-rich apoproteins. It was indeed shown that histone H1, the richest in lysine, was the preferred substrate of NCS (23). Histones combine with DNA to form
nucleosomes which are connected by histone H1. Based on the proteolytic
capacity of the apoprotein, it has been suggested that the apoprotein
is directly involved in the activity of the chromoprotein complex, providing active chromophores with easier access to their DNA target
(23). These results have suggested that the protein
component of these chromoproteins may provide a targeted delivery of
the chromophores to the chromatine.
The association of the two unrelated properties, chromophore binding
and enzymatic activity, in the same single domain protein rises
important evolutionary questions. This might result from an
evolutionary process that conferred a new proteolytic activity on a
preexisting binding protein. Alternatively, a preexisting protease may
have subsequently acquired strong and highly specific binding
properties. As the various proteins belong to the same superfamily with
a high level of identity between their amino acid sequences, and as all
bind enediyne-containing chromophores, a divergent evolutionary process
for chromophore binding appears to be the most likely origin.
Furthermore, the different proteolytic activities observed in this
chromoprotein family suggest that these activities may result from
different adaptations of a preexisting binding protein. None of these
proteins have sequence or structural similarity to any known protease
family. This interesting situation, and the possible intriguing
underlying evolutionary mechanism, led us to analyze the mechanistic
basis for the activities of this potentially new family of proteases,
starting with neocarzinostatin, the most studied family member.
A protein engineering strategy could be a powerful way to analyze the
molecular basis of this catalytic activity. However, no expression
system for producing recombinant apo-NCS had been described. We
therefore constructed a synthetic gene and an expression vector for
producing apo-NCS in Escherichia coli. We then compared the
structural and functional properties of recombinant apo-NCS produced in
E. coli with the same protein naturally produced by S. carzinostaticus. Full characterization of these proteins gave direct evidence that the proteolytic activity observed with both the
recombinant and natural proteins was due not to the apoprotein but to
minor contaminating proteases.
 |
MATERIALS AND METHODS |
NCS apoprotein produced from S. carzinostaticus.
A 200-ml culture of S. carzinostaticus was grown for 48 h as described by Kikushi et al. (12). NCS apoprotein was
purified as described by Favaudon (6). In this protocol, the
naturally produced apoprotein is separated from the holoprotein by
ion-exchange chromatography on carboxymethyl cellulose.
Expression system.
A synthetic gene coding for NCS was
synthesized by assembling eight overlapping oligonucleotides by PCR.
The nucleotide sequence was designed to incorporate several unique
restriction sites, and E. coli codon usage was taken into
account. This gene was inserted into the expression vector pET12a
(NOVAGEN), to give the expression plasmid pNCS.sec. In this construct,
the coding sequence is fused to the ompT signal sequence, to
direct secretion of the target protein into the periplasm. The E. coli strain used for expression was BLR (DE3)pLysS.
Purification of the neocarzinostatin apoprotein secreted by
E. coli.
Cells freshly transformed with the expression
vector were grown on 2YT medium containing ampicillin, tetracycline,
and chloramphenicol at 30°C. The culture medium was separated from
the bacteria, and soluble proteins directly secreted into the culture
medium were precipitated with 650 g of ammonium sulfate per liter.
The proteins were collected by centrifugation for 20 min at
17,000 × g. The precipitate was dialyzed first against
double-distilled water and then against 20 mM ammonium acetate buffer
(pH 5). The protein solution was applied to a Q Sepharose Fast Flow
column equilibrated with 20 mM ammonium acetate buffer (pH 5). Proteins
were eluted with 500 mM ammonium acetate (pH 5) at a flow rate of 4 ml/min. The eluate was then applied to a Sephadex G-50 column
equilibrated with 50 mM phosphate buffer (pH 7) and eluted at a flow
rate of 0.5 ml/min.
Purification of protein substrates.
Histone H1 was purified
from calf thymus as described by de Nooij et al. (5), and
apocytochrome c was purified by the silver sulfate method of
Paul, as modified by Fisher et al. (7).
Physicochemical properties of the recombinant apo-NCS.
The
amino acid sequence of the recombinant was analyzed on an Applied
Biosystems model 473A microsequencer, and the molecular weight of the
recombinant protein was determined by electrospray and matrix-assisted
laser desorption ionization-time-of-flight mass spectrometry using
standard methods.
Circular dichroism (CD) spectra were recorded from 180 to 260 nm on a
Mark V dichrograph (Jobin-Yvon) equipped with a thermostatically controlled cell holder and connected to a computer for data
acquisition. Data were acquired from 15 µM sample solutions in
phosphate buffer using quartz cells with a 0.1-mm path length. One and
two-dimensional nuclear magnetic resonance (NMR) spectra were recorded
on a 500-MHz Varian spectrometer, using the conditions described
elsewhere (1, 2).
Ethidium bromide (EtBr) binding to apo-NCS (
15) was studied
by fluorimetry with an Aminco SLM 8000 fluorimeter, by monitoring
the
intrinsic fluorescence of a 1.75 µM EtBr solution
(
exc =
479 nm,
em = 620 nm) as
a function of apo-NCS concentration.
Saturation curve data was analyzed
by using the following equation:
|
(1)
|
where
Fmax equals
Fmax
F0,
F equals
F
F0, and
F and
F0 are the fluorescence
intensities measured in the presence and
absence of the protein,
respectively,
P0 is the total protein
concentration,
B0 is the total EtBr
concentration, and
Kd is the
dissociation
constant.
Proteolytic activity measurements.
Apo-NCS (0.1 mg/ml) was
incubated with protein substrate (1 mg/ml) in 50 mM Tris-HCl buffer (pH
7.5) at 37°C in a total volume of 100 µl. The mixture was subjected
to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
in a 12% gel, and the protein bands were stained with Coomassie blue.
For the synthetic peptide, (WAGKTPVKKASGPW; supplied by NEOSYSTEM),
the mixture was analyzed by high-pressure liquid chromatography on a
Vydac C18 column equilibrated in 0.1% trifluoroacetic acid
in water with elution by a 0 to 80% acetonitryl-0.1% trifluoroacetic
acid gradient.
Purification of apo-NCS antibody.
Apo-NCS serum was obtained
by hyperimmunization of a rabbit by intradermal injections of apo-NCS
emulsified within complete Freund's adjuvant. Subsequent booster
injections were administrated at intervals of 3 weeks under the same
conditions. The rabbit was bled 1 week after each booster injection.
Apo-NCS antibodies were purified from the serum by affinity
chromatography on an immobilized apo-NCS column. The column used was a
Hitrap N-hydroxysuccinimide-activated column grafted with
pure recombinant apo-NCS as recommended by the supplier. The rabbit
serum was applied to this column, and elution was performed with 50 mM
glycine-100 mM NaCl (pH 2.5). Fractions were neutralized immediately
after elution by adding one-fifth the volume of 1 M Tris-HCl buffer at
pH 9.
Thermal stability of apo-NCS.
The thermal stability and
reversibility of heat denaturation were studied by differential
scanning calorimetry (DSC) on a Microcal model MC2. DSC measurements
were made with a 3-mg/ml apo-NCS solution dialyzed overnight against
phosphate buffer (pH 7.5). Buffer solution from the dialysis bath was
used as a reference. All solutions were degassed just before loading
into the calorimeter. Scanning was performed at 1 K/min, and the
reversibility of the thermal transition was checked by rescanning the sample.
 |
RESULTS |
Growing conditions.
The initial aim of the experiments
reported was to produce recombinant apo-NCS to enable us to define
clearly the role of the apoprotein in proteolytic activity and to
identify, by mutagenesis, the residues involved in this activity. The
first step was to obtain a large amount of recombinant functional
apoprotein. Growth conditions and purification methods were optimized
so as to overproduce soluble protein. Our first attempts showed that
growing the cells at 37°C led mostly to the production of apo-NCS in
the form of inclusion bodies. When the temperature was decreased to
30°C, the recombinant protein was mostly secreted into the culture
medium (Fig. 1) in a soluble, folded
form.

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-PAGE of cells crude lysate of a culture incubated at
37°C (lane 1), culture supernatant after growth at 37°C (lane 2),
cells crude lysate of a culture incubated at 30°C (lane 3), and
culture supernatant after growth at 30°C (lane 4). The arrows show
the band corresponding to apo-NCS.
|
|
Characterization of the recombinant protein.
The recombinant
protein was fully characterized to check that it is strictly equivalent
to the natural apo-NCS. We first checked that the mature product is
completely devoid of the signal peptide encoded by the synthetic gene.
The N-terminal sequence was AAPTATVP, identical to that of the natural
protein, indicating that the peptide signal was correctly processed.
Mass spectrometry indicated the presence of a single species with a
molecular mass of 11,100 Da. Thus, the recombinant protein was
homogeneous, of the expected size, and without any proteolysis on the
N- or C-terminal end, excepted for cleavage of the synthetic signal
peptide. SDS-PAGE showed one well-resolved band with no visible
contaminants on an overloaded gel.
CD spectra for natural apo-NCS and the recombinant protein were
recorded in identical conditions. The two spectra are fully
superimposable (Fig.
2). NCS is an
all-

protein, but the general
shape of the CD spectra is somewhat
atypical, with a positive
maximum at 225 nm. This CD signal may result
from constraints
in the polypeptide backbone. The presence of disulfide
bridges
connecting cysteine residues very close together at positions
37 to 47 and 88 to 93 may account for such signal reported as
"not
typical" secondary structures (
16).
One-dimensional
1H NMR spectra of natural and recombinant
apo-NCS are very similar, the peaks having similar chemical shifts
and
relative intensities (Fig.
3),
illustrating the perfect identity
of natural and recombinant apo-NCS.
It has previously been shown
that EtBr binds to apo-NCS at the natural
chromophore site (
15).
Therefore, EtBr binding provides a
convenient way to monitor the
functional integrity of the binding site
of the recombinant apoprotein.
A
Kd of 2 µM
was obtained for recombinant apo-NCS, similar to
the value previously
reported (
15) for the natural apoprotein
(1 µM),
indicating that the recombinant protein is fully functional.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of the 1H NMR spectra acquired at
500 MHz, in H2O at pH 5.5 and 35°C, of natural (a) and
recombinant (b) proteins.
|
|
Histone H1 cleavage by NCS.
Incubation of calf thymus histone
H1 with natural or recombinant apo-NCS leads to the formation of
low-molecular-weight species (Fig. 4)
within 2 h of incubation. This result is similar to those previously reported (23, 24). However, a noticeable
difference is observed in the proteolytic activity of the recombinant
and natural proteins, because although the concentration of the
recombinant protein was higher, the time required to obtain full
proteolysis of the sample was 10 times longer than for natural NCS.
Thus, the proteolytic activity of apo-NCS purified from E. coli is lower than the proteolytic activity of the apoprotein
purified from S. neocarzinostaticus.

View larger version (98K):
[in this window]
[in a new window]
|
FIG. 4.
SDS-PAGE analysis of the reaction of apo-NCS with calf
thymus histones. Reaction conditions: 50 mM Tris-HCl buffer (pH 7.5),
histones (1 mg/ml), and recombinant (500 µg/ml) (A) or natural (100 µg/ml) apo-NCS (B) in a total volume of 100 µl. Numbers are
incubation times (hours) for each sample.
|
|
Specificity of the proteolytic activity.
Previous studies
concerning the proteolytic activity of apo-NCS have shown higher levels
of proteolytic activity for apo-NCS with histone H1 than with other
proteins. We used various proteins as substrates and determined the
specificity of recombinant and natural apo-NCS. Of the proteins other
than histone H1 tested (RNase,
-lactalbumin, albumin, carbonic
anhydrase, cytochrome c, and apo-cytochrome c),
only apo-cytochrome c was cleaved by both types of NCS.
Cytochrome c and apo-cytochrome c are highly basic proteins. Apo-cytochrome c is known to be a very
flexible and loosely folded protein (17). Histone H1 is also
a highly flexible protein (4). Thus, in addition to its
basic character, the main reason for the apparent specificity of
apo-NCS for histone H1 seems to be the high degree of flexibility of
histone H1 rather than its specific tertiary structure.
Proteolytic activity was also tested against a synthetic peptide, the
sequence of which (WAGKTPVKKASGPW) was derived from
the peptides used
in previous studies (
23). We monitored hydrolysis
products
by adding two tryptophans, one at each extremity of the
peptide.
According to Zein et al. (
23), there are two cleavage
sites,
between Lys-Lys and Lys-Ala. As expected, the apo-NCS from
Streptomyces cleaves this peptide (Fig.
5). Although proteolysis
was not
complete, the number of peptides detected at 220 and 280
nm clearly
indicates that the peptide was cleaved at at least
two positions.
However, in the same experimental conditions, the
apo-NCS from
E. coli has no proteolytic activity against this
peptide (data not
shown).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 5.
Chromatography elution of proteolysate of the synthetic
peptide treated with apo-NCS from Streptomyces, monitored at
215 (A) and 280 (B) nm.
|
|
Inhibition of proteolytic activity.
We investigated the
possible involvement of the chromophore binding site residues in
catalytic activity by studying apo-NCS proteolytic activity in the
presence of 50 µM EtBr. No significant effect was observed for either
of the two proteins, suggesting that the amino acids involved in
proteolytic activity are located outside the binding site of the
chromophore. Similarly, serine protease inhibitors such as
phenylmethylsulfonyl fluoride and 4-2-aminoethyl-benzosulfonyl-fluorohydrochloride (EABSF) did not affect
proteolytic activity. EDTA, however, strongly inhibited the proteolytic
activity associated with apo-NCS from S. carzinostaticus but
did not inhibit the proteolytic activity associated with the recombinant form of apo-NCS (Fig. 6).
These results suggest that the proteolytic activities detected in the
two preparations are due to different compounds.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 6.
SDS-PAGE analysis of the inhibition of proteolytic
activity by EDTA. Lane 1, histone; lane 2, histone plus apo-NCS from
Streptomyces; lane 3, histone + apo-NCS from
Streptomyces plus EDTA; lane 4, histone plus apo-NCS from
E. coli; lane 5, histone + apo-NCS from E. coli plus EDTA.
|
|
Thermostability of apo-NCS and proteolytic activity.
NCS is a
thermostable protein with a melting transition at 68°C. Figure
7 shows the buffer-corrected partial
molar excess heat capacity data for a 3-mg/ml recombinant apo-NCS
solution in phosphate buffer (pH 7.5) at a scan rate of 1 K/min. Under these conditions, the transition occurs with a
H of 100 kcal/mol and a melting temperature of 68°C, as for natural
apoprotein. The reversibility of the thermal transition was checked by
rescanning the sample. Three successive scans were performed, showing a
high degree of reversibility, with 90% recovery of the denaturation enthalpy. It should be emphasized that the DSC profile is a highly sensitive indicator of the folded structure and that the observed reversibility unambiguously demonstrates that NCS thermal denaturation is a highly reversible process. In contrast, a single heating at
80°C, in the conditions used for DSC measurements, of both types of
apo-NCS sample (from S. neocarzinostaticus and from E. coli) led to full inactivation of the associated proteolytic
activity.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 7.
Corrected partial molar excess heat capacity for a
3-mg/ml apo-NCS solution in phosphate buffer (pH 7.5) at a scan rate of
1 K/min. The profiles obtained for two consecutive scans are shown.
|
|
Separation of apoprotein and proteolytic activity.
We
attempted to separate proteolytic activity from apo-NCS in two ways.
First, ion-exchange chromatography on a Mono Q FPLC column equilibrated
with 50 mM amonium acetate buffer (pH 7.5) was performed on a stock
solution of NCS displaying proteolytic activity. Elution with a
gradient of NaCl gave a single peak corresponding to apo-NCS (Fig.
8). Although no proteolytic activity was
found elsewhere in the gradient, nor eluted by a step at 1 M NaCl, the protein recovered was found to have a relative activity corresponding to less than 5% of that of the same sample before chromatography. This
suggests that activity could be minimized by repeated purification.

View larger version (8K):
[in this window]
[in a new window]
|
FIG. 8.
Elution profile of an ion-exchange chromatography on a
Mono Q FPLC column (0.5 by 5 cm) of a stock solution of NCS with a
gradient of 0 to 0.3 M NaCl (flow rate, 1 ml/min). Proteolytic activity
was observed only in the fraction containing protein (+). The apparent
specific activity of this fraction was 5% of the apparent specific
activity before chromatography, as estimated from the time required to
proteolyze 50% of histone H1.
|
|
In the second method, we used polyclonal antibodies to separate
proteolytic activity from apo-NCS. In a first step, stock
solutions of
apo-NCS from
S. neocarzinostaticus or
E. coli
were
incubated with affinity-purified anti-NCS rabbit polyclonal
antibodies.
The antibody-NCS complex was then trapped by adding
agarose beads
cross-linked with protein A which were removed by
centrifugation.
As expected, NCS was no longer detectable in the
supernatant by
SDS-PAGE, indicating that all apo-NCS molecules were
trapped by
antibodies. However, the supernatant, which did not contain
apo-NCS,
had the same level of proteolytic activity as the original
preparations,
indicating that proteolytic activity can be physically
separated
from apo-NCS molecules (Fig.
9). Control experiments conducted
with
the same reagents but with no added apo-NCS showed that the
sole source
of proteolytic activity in these experiments was the
apo-NCS
preparations. The clear conclusion of this experiment
is that the
observed proteolytic activity of recombinant and natural
apo-NCS,
similar in all respects to previously published observations,
can be
physically separated from apoprotein and is due to a molecular
species
other than apo-NCS.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 9.
SDS-PAGE analysis of the inhibition of proteolytic
activity by specific anti-NCS antibodies. Lane 1, histone; lane 2, histone plus apo-NCS; lane 3, histone plus supernatant from
immunoprecipitation of apo-NCS (see text); lane 4, purified apo-NCS.
|
|
 |
DISCUSSION |
Since the discovery of NCS and the DNA cleavage activity
associated with the chromophore, many studies have been performed to
elucidate and optimize antitumoral activity. In the last decade, related proteins have been purified; in the course of these studies, it
has been suggested that a proteolytic activity is associated with the
apoproteins, with proteolytic specificity apparently unique to each
chromoprotein (23). The proteolytic activity appeared to be
selective for histones, particularly histone H1. It was therefore
suggested that these highly acidic apoproteins protected their
chromophores from deactivation and delivered them to the spacer DNA
after cleaving histone H1 (22). We have reinvestigated this
proteolytic activity by using a recombinant apo-NCS produced by
expression of a synthetic gene in E. coli. The recombinant apo-NCS is strictly devoid of the chromophore, and this method makes it
possible to construct any mutant required to characterize the amino
acids directly involved in the proteolytic process.
Full characterization of the recombinant apoprotein showed that it is
strictly identical to the natural apo-NCS. Chemical characterization by
microsequencing and mass spectrometry showed that it is uniformly
processed. Structural properties, as monitored by far-UV CD and NMR,
indicate that the recombinant protein is correctly folded. EtBr bound
efficiently to recombinant apo-NCS. These data clearly indicate that
the recombinant apo-NCS is correctly folded.
The recombinant and natural proteins were indistinguishable with
respect to physicochemical properties but differed in proteolytic activities. As previously shown (23), histone H1 is cleaved by both natural and recombinant apo-NCS, but this activity of the
recombinant apoprotein is weaker. However, the first data to indicate a
clear difference in the proteolytic activities of the two forms of
neocarzinostatin came from the hydrolysis of the synthetic peptide. The
peptide is fully cleaved by the apo-NCS prepared from S. carzinostaticus, but the apo-NCS extracted from E. coli
does not cleave it at all. This suggests that the amino acid sequences
recognized are different in the two cases. Moreover, the effect of EDTA
on proteolytic activity indicates that the activity associated with
apo-NCS from S. carzinostaticus was dependent on divalent
cations. In contrast, EDTA does not affect the proteolytic activity
associated with apo-NCS from E. coli. These results provide strong evidence for there being two different origins of proteolytic activities according to the source of apo-NCS. Taking into account the
high level of identity of the natural and recombinant apoproteins, this
suggests that the proteolytic activity is not directly related to
apoprotein structure but may result from minor protease contaminants different in nature for the two sources. This possibility was raised in
previous studies, but the authors proposed that their data suggested,
within reasonable limits, that the proteolytic activity observed was
not due to minor protease activity (22).
It should be noted that according to standard purity criteria, the
apo-NCS preparations used here and in previous studies were classed as
pure proteins. Staining with Coomassie blue detected a single band on
the polyacrylamide gel, even if the gel was overloaded. Similarly, only
one species was detected by mass spectrometry.
Other observations suggested that the proteolytic activity is actually
due to a protein other than the apo-NCS. Ion-exchange chromatography
reduced significantly the specific proteolytic activity of apo-NCS
indicating that functional apo-NCS could be separated from the
proteolytically active component by repeated purification. The addition
of polyclonal antibodies to the reaction mixture did not affect the
proteolytic activity (data not shown).
Although consistent, these data are not fully conclusive: although the
specific proteolytic activity is strongly reduced by ion-exchange
chromatography, it is not completely abolished, and it is therefore
possible that various isoforms of the protein are present or that there
is an indispensable cofactor required for proteolytic activity.
Similarly, the lack of an effect of polyclonal antibodies on
proteolytic activity may result from the absence of an inhibitory
antibody, although such hypothesis seems unlikely with polyclonal antibodies.
The definitive data come from thermal denaturation experiments and
trapping of the apo-NCS-antibody complex. Thermal denaturation studies
showed that unfolding is reversible for apo-NCS but causes irreversible
inactivation of proteolytic activity for both apo-NCS (recombinant and
natural). Finally, the use of specific anti-NCS antibodies made it
possible to physically separate apo-NCS from the proteolytic activity
present in the preparations. Apo-NCS was very specifically removed from
the incubation mixture by trapping the apo-NCS-anti-NCS antibody
complex on protein A-agarose beads, and the levels of proteolytic
activity were similar in the NCS preparation and in the supernatant
devoid of apo-NCS. Clearly, if proteolysis was due to a weakly active
apo-NCS or to a small proportion of apo-NCS molecules with proteolytic
activity, a decrease in activity proportional to the quantity of NCS in
the medium would have been observed.
The simplest interpretation of these results is that a minor
contaminant with proteolytic activity is present. This would also
explain why proteins with similar structures and sequences are
associated with various proteolytic activities, from exopeptidase to
endopeptidases (18, 21, 22, 24). The activity being due to a
contaminant would also account for the very low specific activity: the
experimental conditions used (apoprotein/substrate ratio, incubation
time) indicate a specific activity at least 3 orders of magnitude lower
than that of typical proteases like trypsin. The observed specificity
for histone H1, which was thought to be a biologically relevant
property, can be due not only to the amino acid sequence of the
substrate but also to its flexibility. NCS proteolytic activity was
measured for various proteins possessing at least one cleavage site,
according to Zein et al. (23). These experiments suggested
that the specificity could be related to the structure of histone H1.
This protein has a structured domain and a flexible domain; the
flexible part of the protein could be responsible for the high
susceptibility to proteolysis of histone H1. This hypothesis is
supported by the difference in the susceptibility to proteolysis of
cytochrome c and apo-cytochrome c. Histone H1, due to its high flexibility, is a highly sensitive proteolytic substrate, as is apo-cytochrome c. It may be possible to
detect minor proteolytically active contaminant with histone H1 that would probably not be detected with other substrates.
These results exclude previous hypotheses concerning the possible
physiological role of this activity. As apo-NCS has no intrinsic proteolytic activity, it does not necessarily have to reach DNA to
cause its cleavage; thus, the primary function of the apoprotein is
probably to stabilize and regulate the availability of the labile
chromophore. It is not clear whether the holo-NCS enters the cell and
releases the chromophore at its site of action or whether it releases
the chromophore at the cell surface to be carried inside. It has been
shown that holo-NCS can be taken up by the cells, but Lazarus et al.
(14), by using holo-NCS covalently bond to agarose, have
shown that the chromophore released at the cell surface can be taken up
by the cell. If holoprotein uptake is not required for chromophore
activity, these experiments do not determine whether holo-NCS is
ordinarily taken up intact if cells are treated with the drug. Our
results are consistent with holo-NCS-induced chromatin cleavage
experiments showing that histone H1 is not specifically cleaved by this
treatment (3). We believe that the protocol used by us and
others to detect apo-NCS proteolytic activity is extremely sensitive
and consequently very likely to generate false-positive artifacts.
The results presented herein clearly raise the possibility that low
levels of various proteolytic activities described for other
chromoproteins may also be due to the proteolytic activities of minor
contaminants. They strongly suggest that more definitive evidence, for
example, the abolition of activity by directed mutations, is required
for such activities to be considered reliable and biologically relevant.
 |
ACKNOWLEDGMENTS |
This work was supported by the Centre National de la Recherche
Scientifique, by the Ministère de l'Enseignement Supérieur et de la Recherche, and by a contract with the Institut Curie.
Bernadette Heyd and Guilhem Lerat contributed equally to this work and
thus should be considered co-first authors.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratoire de
Modélisation et d'Ingénierie des Protéines, EP1088,
Université de Paris-Sud, Bât 430, F-91405 Orsay Cedex,
France. Phone: 33-1-69-15-79-75. Fax: 33-1-69-85-37-15. E-mail:
michel.desmadril{at}mip.u-psud.fr.
 |
REFERENCES |
| 1.
|
Adjadj, E.,
J. Mispelter,
E. Quiniou,
J.-L. Dimicoli,
V. Favaudon, and J.-M. Lhoste.
1990.
Proton NMR studies of apo-neocarzinostatin from Streptomyces carzinostaticus. Sequence-specific assignment and secondary structure.
Eur. J. Biochem.
190:263-271[Medline].
|
| 2.
|
Adjadj, E.,
E. Quiniou,
J. Mispelter,
V. Favaudon, and J. M. Lhoste.
1991.
Three-dimensional solution structure of apo-neocarzinostatin from Streptomyces carzinostaticus determined by NMR spectroscopy.
Eur. J. Biochem.
203:505-511[Medline].
|
| 3.
|
Beerman, T. A.,
G. Mueller, and H. Grimmond.
1982.
Effects of neocarzinostatin on chromatin in HeLa S3 nuclei.
Mol. Pharmacol.
23:493-499[Abstract].
|
| 4.
|
Bradbury, E. M.
1983.
Conformations and flexibilities of histones and high mobility group (HMG) proteins in chromatin structure and function.
Ciba Found. Symp.
93:246-270[Medline].
|
| 5.
|
de Nooij, E. H., and H. G. K. Westenbrink.
1962.
Isolation of a homogenous Lys-rich histone from calf thymus.
Biochim. Biophys. Acta
62:608-609[Medline].
|
| 6.
|
Favaudon, V.
1983.
Gamma-radiolysis study of the reductive activation of neocarzinostatin by the carboxyl radical.
Biochimie
65:593-607[Medline].
|
| 7.
|
Fisher, W. R.,
H. Taniuchi, and C. B. Anfinsen.
1973.
On the role of heme in the formation of the structure of cytochrome c.
J. Biol. Chem.
248:3188-3193[Abstract/Free Full Text].
|
| 8.
|
Goldberg, I. H.,
T. Hatayama,
L. S. Kappen,
M. A. Napier, and L. F. Povirk.
1981.
Molecular actions and targets for cancer chemiotherapeutic agents, vol. 1. , p. 163-191.
Academic Press, New York, N.Y.
|
| 9.
|
Hatayama, T., and M. Yukioka.
1982.
Action of neocarzinostatin on cell nuclei: release of specific chromatin.
Biochem. Biophy. Res. Commun.
104:889-896[CrossRef][Medline].
|
| 10.
|
Kappen, L. S.,
T. E. Ellenberger, and I. H. Goldberg.
1987.
Mechanism and base specificity of DNA breakage in intact cells by neocarzinostatin.
Biochemistry
26:384-390[CrossRef][Medline].
|
| 11.
|
Kappen, L. S.,
M. A. Napier, and I. H. Goldberg.
1980.
Roles of chromophore and apoprotein in neocarzinostatin action.
Proc. Natl. Acad. Sci. USA
7:1970-1974.
|
| 12.
|
Kikushi, M.,
M. Shoji, and N. Ishida.
1974.
Pre-neocarzinostatin, a specific antagonist of neocarzinostatin.
J. Antibiot.
27:766-774[Medline].
|
| 13.
|
Kim, K.-H.,
B.-M. Kwon,
A. G. Myers, and D. R. Rees.
1993.
Crystal structure of neocarzinostatin, an antitumor protein-chromophore complex.
Science
262:1042-1046[Abstract/Free Full Text].
|
| 14.
|
Lazarus, H.,
V. Raso, and T. S. A. Samy.
1977.
In vitro inhibition of human leukemic cells CCRF-CEM) by agarose-immobilized neocarzinostatin.
Cancer Res.
37:3731-3138[Abstract/Free Full Text].
|
| 15.
|
Mohanty, S.,
L. C. Sieker, and G. P. Drobny.
1994.
Sequential 1H NMR assignment of the complex of aponeocarzinostatin with ethidium bromide and investigation of protein-drug interactions in the chromophore binding site.
Biochemistry
33:10579-10590[CrossRef][Medline].
|
| 16.
|
Perczel, A., and M. Hollosi.
1996.
Turns, p. 285-381.
In
G. Fasman (ed.), Circular dichroism and the conformational analysis of biomolecules. Plenum Press, New York, N.Y.
|
| 17.
|
Privalov, P. L.,
E. I. Tiktopulo,
S. Venyaminov,
Y. V. Griko,
G. I. Makhatadze, and N. N. Khechinashvili.
1989.
Heat capacity and conformation of proteins in the denatured state.
J. Mol. Biol.
205:737-750[CrossRef][Medline].
|
| 18.
|
Sakata, N.,
K. S. Tsuchiya,
Y. Moriya,
H. Hayashi,
M. Hori,
T. Otani,
M. Nagai, and T. Aoyagi.
1991.
Aminopeptidase activity of an antitumor antibiotic, C-1027.
J. Antibiot.
45:113-117.
|
| 19.
|
Teplyakov, A.,
G. Obmolova,
K. Wilson, and K. Kuromizu.
1993.
Crystal structure of apo-neocarzinostatin at 0.15-nm resolution.
Eur. J. Biochem.
213:737-741[Medline].
|
| 20.
|
Tien, K. M., and T. S. A. Samy.
1978.
Effects of neocarzinostatin on mammalian nuclei: release of nucleosomes.
Biochim. Biophys. Acta
518:186-190[Medline].
|
| 21.
|
Zaheer, A.,
S. Zaheer, and R. Montgomery.
1985.
Peptidase activity of macromomycin apoprotein.
J. Biol. Chem.
260:11787-11792[Abstract/Free Full Text].
|
| 22.
|
Zein, N.,
A. M. Casazza,
T. W. Doyle,
J. E. Leet,
D. R. Schroeder,
W. Solomon, and S. G. Nadler.
1993.
Selective proteolytic activity of the antitumor agent kedarcidin.
Proc. Natl. Acad. Sci. USA
90:8009-8012[Abstract/Free Full Text].
|
| 23.
|
Zein, N.,
W. Solomon,
K. L. Colson, and D. R. Schroeder.
1995.
Maduropeptin: an antitumor chromoprotein with selective protease activity and DNA cleaving properties.
Biochemistry
34:11591-11597[CrossRef][Medline].
|
| 24.
|
Zein, N.,
P. Reiss,
M. Bernatowicz, and M. Bolgar.
1995.
The proteolytic specificity of the natural enediyne-containing chromoproteins is unique to each chromoprotein.
Chem. Biol.
7:451-455[CrossRef].
|
Journal of Bacteriology, April 2000, p. 1812-1818, Vol. 182, No. 7
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hariharan, P., Liang, W., Chou, S.-H., Chin, D.-H.
(2006). A New Model for Ligand Release: ROLE OF SIDE CHAIN IN GATING THE ENEDIYNE ANTIBIOTIC. J. Biol. Chem.
281: 16025-16033
[Abstract]
[Full Text]
-
Nicaise, M., Valerio-Lepiniec, M., Izadi-pruneyre, N., Adjadj, E., Minard, P., Desmadril, M.
(2003). Role of the tyrosine corner motif in the stability of neocarzinostatin. Protein Eng Des Sel
16: 733-738
[Abstract]
[Full Text]
-
Valerio-Lepiniec, M., Nicaise, M., Adjadj, E., Minard, P., Desmadril, M.
(2002). Key interactions in neocarzinostatin, a protein of the immunoglobulin fold family. Protein Eng Des Sel
15: 861-869
[Abstract]
[Full Text]
-
Christopher, G., Sudhahar, P., Balamurugan, K., Chin, D.-H.
(2000). Release of the Neocarzinostatin Chromophore from the Holoprotein Does Not Require Major Conformational Change of the Tertiary and Secondary Structures Induced by Trifluoroethanol. J. Biol. Chem.
275: 39900-39906
[Abstract]
[Full Text]